Oliver Lagore Vanvalin Investment Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $977K | Buy |
|
|||||
|
2024
Q4 | $2.1M | Buy |
|
|||||
|
2024
Q3 | $1.87M | Sell |
|
|||||
|
2024
Q2 | $2.34M | Buy |
|
|||||
|
2024
Q1 | $1.9M | Buy |
|
|||||
|
2023
Q4 | $1.25M | Buy |
|
|||||
|
2023
Q3 | $650K | Buy |
|
|||||
|
2023
Q2 | $347K | Buy |
|
|||||
|
2023
Q1 | $143K | Buy |
|
|||||
|
2022
Q4 | $1.76K | Hold |
|
|||||
|
2022
Q3 | $1K | Buy |
|